Harpoon Therapeutics Inc. (HARP): Shedding Light on Earning Per Share Reports


Harpoon Therapeutics Inc. (NASDAQ:HARP) changes shares on Tuesday trading session, with a change of 8.72% or $1.05 shares. The trading starts at $11.82 and closed at $12.04 throughout the day. The trading session low price was $11.82 and day high was $13.54 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.2 million while its average volume is 195.05K. In other hand, the HARP market cap reached to $340.21M.

On July 2, 2020, BRIEF-Harpoon Therapeutics Reports Changes To Board Of Directors. According to the news reported on Reuters, * HARPOON THERAPEUTICS ANNOUNCES CHANGES TO BOARD OF DIRECTORS

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 1.71% and down -20.38% for month. Its quarterly performance was -2.75% below, while its half year performance is down -10.65%. HARP yearly performance stood at positive 0.54% and fall -11.49% for year-to-date. Current recommendation for Harpoon Therapeutics Inc. is 1.40.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. HARP EPS (TTM) for 12-month is -2.25. EPS for this year is -123.30%, while for the next year its value is -2.04. Its EPS Q/Q reached 9.30%.

Let’s take a look on the analyst recommendations on HARP for the current month and previous month. For the current month, 8 of 9 analysts recommend stock as Buy while 0 as Sell, 1 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 9 analysts participate in stock recommendation. Out of 9, 0 rated it sell, 8 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $24.00 – $36.00. Average target price for HARP was reached at $30.89.

MPM Asset Management, LLC, MPM ONCOLOGY IMPACT MANAGEMENT LP and New Leaf Venture Partners, L.l.c. are the top three holders in Harpoon Therapeutics Inc. (HARP) stock. On Mar 30, 2020, MPM Asset Management, LLC has 4.52 million shares which valued 52.39 million. On Mar 30, 2020, MPM ONCOLOGY IMPACT MANAGEMENT LP owned 3.9 million shares which valued at 45.14 million. On Mar 30, 2020, New Leaf Venture Partners, L.l.c. has a total of 2.92 million shares which valued at 33.83 million. In the end, New Leaf Venture Partners, L.l.c. have 11.69% shares outstanding of Harpoon Therapeutics Inc. (HARP) on Mar 30, 2020. The insider ownership moved to 0.40% and institutional holding shifted to 77.70%.

The company posted an EPS (TTM) of -2.25. According to the most recent quarter report on (Jun 2020), 9 analysts estimated an average EPS of -0.47, while -0.49 EPS posted a year ago period. Analyst Estimated EPS for HARP published in the report was -$0.61 – -$0.3 during the same period. Comparing with last year, the average estimated EPS was -0.49 which is higher than -0.51 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for HARP fall -12.64% for period of 200 days. SMA for 50 days was -21.91% which is showing red signal, while SMA-20 was -8.28%. The moving average value for Harpoon Therapeutics Inc. (HARP) is 220.83k and 2.09% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in HARP stock. On Jul 31, Erbez Georgia, Chief Financial Officer, bought 1,817 trading shares at the cost of $10.92, which valued at 19842.0. On Jul 01, Wesche Holger, Chief Scientific Officer, sold 10,000 shares at the cost of $16.20, with total shares of 52,669. On May 28, Arix Bioscience plc, 10% Owner, sold 366,591 shares at the cost of 21.33. After this transaction, Arix Bioscience plc total shares reached to 2,193,704 which valued at 7.82 million.